Longeveron Inc. (LGVN)
NASDAQ: LGVN
· Real-Time Price · USD
1.18
-0.01 (-0.84%)
At close: Jun 05, 2025, 3:59 PM
1.16
-1.29%
After-hours: Jun 05, 2025, 07:49 PM EDT
-0.84% (1D)
| Bid | 1.14 |
| Market Cap | 17.64M |
| Revenue (ttm) | 2.23M |
| Net Income (ttm) | -16.92M |
| EPS (ttm) | -1.35 |
| PE Ratio (ttm) | -0.87 |
| Forward PE | -1.02 |
| Analyst | Buy |
| Ask | 1.21 |
| Volume | 64,483 |
| Avg. Volume (20D) | 150,625 |
| Open | 1.22 |
| Previous Close | 1.19 |
| Day's Range | 1.17 - 1.23 |
| 52-Week Range | 0.77 - 6.40 |
| Beta | 0.37 |
About LGVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LGVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LGVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-0.65%
Longeveron shares are trading higher after the com...
Unlock content with
Pro Subscription
10 months ago
+0.87%
Longeveron shares are trading higher after the company announced study results from the CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer's disease, meeting its key objectives to advance data supporting a favorable benefit/risk profile.
